Provided by Tiger Trade Technology Pte. Ltd.

SciSparc Ltd.

0.5002
-0.0548-9.87%
Volume:290.03K
Turnover:143.97K
Market Cap:2.18M
PE:-0.02
High:0.5296
Open:0.4900
Low:0.4621
Close:0.5550
52wk High:10.82
52wk Low:0.4621
Shares:4.35M
Float Shares:3.77M
Volume Ratio:3.44
T/O Rate:7.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.6549
EPS(LYR):-22.6549
ROE:-1281.49%
ROA:-42.05%
PB:--
PE(LYR):-0.02

Loading ...

SciSparc to Acquire Xylo’s MUSE Endoscopy IP Portfolio

Reuters
·
Nov 26, 2025

Scisparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems

THOMSON REUTERS
·
Nov 26, 2025

Scisparc Ltd - Upon Deal Close, to Issue Shares Representing 19.99% to Xylo

THOMSON REUTERS
·
Nov 26, 2025

SciSparc, Clearmind Medicine file Israeli patent application for depression

TIPRANKS
·
Nov 20, 2025

Scisparc: Neurothera Labs Announces Israeli Patent Application in Collaboration With Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

THOMSON REUTERS
·
Nov 20, 2025

N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers

GlobeNewswire
·
Oct 30, 2025

N2off Inc. Discloses SciSparc Ltd. as 10% Owner in Initial Beneficial Ownership Filing

Reuters
·
Oct 25, 2025

SciSparc closes acquisition of controlling interest in Neurothera Labs

TIPRANKS
·
Oct 24, 2025

SciSparc Closes Acquisition and Gains Control of Neurothera Labs

Reuters
·
Oct 24, 2025

Scisparc Announces Closing of the Acquisition of a Publicly Traded Company on the Tsxv to Which It Transferred Its Advanced Clinical Stage Pharmaceutical Portfolio

THOMSON REUTERS
·
Oct 24, 2025

SciSparc Closes Sale of MitoCareX to N2OFF

Reuters
·
Oct 24, 2025

Scisparc Announces Closing of the Sale to N2off of Majority-Owned Subsidiary Mitocarex, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Oct 24, 2025

N2OFF Closes Merger with MitoCareX Bio

Reuters
·
Oct 24, 2025

SciSparc Launches Quantum 3D Protein Modeling Initiative for AI Drug Discovery

Reuters
·
Oct 23, 2025

Clearmind Says US Patent Application Published Targeting Binge Behavior Disorders

MT Newswires Live
·
Oct 20, 2025

BRIEF-SciSparc-Clearmind Collaboration Leads to Publication of U.S.Patent Application Targeting Binge Behavior Disorders

Reuters
·
Oct 20, 2025

SciSparc, Clearmind announce publication of U.S. patent application

TIPRANKS
·
Oct 20, 2025

Scisparc Ltd. Announces Asset and Share Purchase Agreement with Province of British Columbia

Reuters
·
Oct 16, 2025

SciSparc enters agreement for acquisition of Miza III Ventures

TIPRANKS
·
Oct 15, 2025

Scisparc Shares Climb 26.7% Premarket After Share Purchase Deal With Miza Iii Ventures

THOMSON REUTERS
·
Oct 15, 2025